{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:01:48Z","timestamp":1779937308115,"version":"3.53.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04295-y","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:38:10Z","timestamp":1776397090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of high chronic obstructive pulmonary disease assessment test scores according to airflow limitation severity: a three-year prospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Hideto","family":"Iizuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Chubachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Fukuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Otake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Tanimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoruko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"4295_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195:557\u201382.","journal-title":"Am J Respir Crit Care Med"},{"key":"4295_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1183\/09031936.00128008","volume":"33","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165\u201385.","journal-title":"Eur Respir J"},{"key":"4295_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","volume":"145","author":"PW Jones","year":"1992","unstructured":"Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George\u2019s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321\u20137.","journal-title":"Am Rev Respir Dis"},{"key":"4295_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-1-13","volume":"28","author":"T van der Molen","year":"2003","unstructured":"van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity, and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;28:13.","journal-title":"Health Qual Life Outcomes"},{"key":"4295_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648\u201354.","journal-title":"Eur Respir J"},{"key":"4295_CR6","doi-asserted-by":"crossref","unstructured":"Kwon N et al. Validity of the COPD assessment test translated into local languages for Asian patients. Chest. 2013;143:703\u201310.","DOI":"10.1378\/chest.12-0535"},{"key":"4295_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1183\/09031936.00177210","volume":"38","author":"PW Jones","year":"2011","unstructured":"Jones PW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38:29\u201335.","journal-title":"Eur Respir J"},{"key":"4295_CR8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1164\/rccm.201110-1843OC","volume":"185","author":"AJ Mackay","year":"2012","unstructured":"Mackay AJ, et al. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med. 2012;185:1218\u201324.","journal-title":"Am J Respir Crit Care Med"},{"key":"4295_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.rmed.2013.08.015","volume":"108","author":"PW Jones","year":"2014","unstructured":"Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108:129\u201335.","journal-title":"Respir Med"},{"key":"4295_CR10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1164\/rccm.200510-1677OC","volume":"173","author":"FJ Martinez","year":"2006","unstructured":"Martinez FJ, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173:1326\u201334.","journal-title":"Am J Respir Crit Care Med"},{"key":"4295_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/15412555.2013.776920","volume":"10","author":"PW Jones","year":"2013","unstructured":"Jones PW. COPD assessment test: Rationale, development, validation, and performance. COPD. 2013;10:269\u201371.","journal-title":"COPD"},{"key":"4295_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000336549","volume":"84","author":"JL Kelly","year":"2012","unstructured":"Kelly JL, et al. Health status assessment in routine clinical practice: The chronic obstructive pulmonary disease assessment test score in outpatients. Respiration. 2012;84:193\u20139.","journal-title":"Respiration"},{"key":"4295_CR13","first-page":"208","volume":"6","author":"J Vestbo","year":"2012","unstructured":"Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management, and prevention of COPD (GOLD): Why and what? Clin. Respir J. 2012;6:208\u201314.","journal-title":"Respir J"},{"key":"4295_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1465-9921-15-13","volume":"15","author":"M Miyazaki","year":"2014","unstructured":"Miyazaki M, et al. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13.","journal-title":"Respir Res"},{"key":"4295_CR15","doi-asserted-by":"publisher","first-page":"106895","DOI":"10.1016\/j.rmed.2022.106895","volume":"201","author":"Y Hamakawa","year":"2022","unstructured":"Hamakawa Y, et al. Non-respiratory symptom dominance is associated with depression in patients with chronic obstructive pulmonary disease. Respir Med. 2022;201:106895.","journal-title":"Respir Med"},{"key":"4295_CR16","first-page":"1737","volume":"10","author":"WT Liu","year":"2015","unstructured":"Liu WT, et al. Low bone mineral density in COPD patients with osteoporosis is related to low daily physical activity and high COPD assessment test scores. Int J Chron Obstruct Pulmon Dis. 2015;10:1737\u201344.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4295_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40248-015-0023-2","volume":"10","author":"RW Dal Negro","year":"2015","unstructured":"Dal Negro RW, Bonadiman L, Turco P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med. 2015;10:24.","journal-title":"Multidiscip Respir Med"},{"key":"4295_CR18","doi-asserted-by":"publisher","first-page":"105810","DOI":"10.1016\/j.rmed.2019.105810","volume":"159","author":"S von Marietta","year":"2019","unstructured":"von Marietta S, et al. CAT score single item analysis in patients with COPD: Results from COSYCONET. Respir Med. 2019;159:105810.","journal-title":"Respir Med"},{"key":"4295_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/resp.12429","volume":"20","author":"S Chubachi","year":"2015","unstructured":"Chubachi S, et al. Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD. Respirology. 2015;20:286\u201395.","journal-title":"Respirology"},{"key":"4295_CR20","doi-asserted-by":"publisher","first-page":"107346","DOI":"10.1016\/j.rmed.2023.107346","volume":"217","author":"T Shimada","year":"2023","unstructured":"Shimada T, et al. Differential impacts between fat mass index and fat-free mass index on patients with COPD. Respir Med. 2023;217:107346.","journal-title":"Respir Med"},{"key":"4295_CR21","first-page":"1269","volume":"11","author":"M Sato","year":"2016","unstructured":"Sato M, et al. Impact of mild exacerbation on COPD symptoms in a Japanese cohort. Int J Chron Obstruct Pulmon Dis. 2016;11:1269\u201378.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4295_CR22","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00535-004-1417-7","volume":"39","author":"M Kusano","year":"2004","unstructured":"Kusano M, et al. Development and evaluation of FSSG: Frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888\u201391.","journal-title":"J Gastroenterol"},{"key":"4295_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"4295_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1164\/rccm.200804-619OC","volume":"178","author":"W Xu","year":"2008","unstructured":"Xu W, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178:913\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"4295_CR25","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1038\/s41598-021-87724-8","volume":"11","author":"A Tsutsumi","year":"2011","unstructured":"Tsutsumi A, et al. Characteristics of chronic obstructive pulmonary disease patients with robust progression of emphysematous change. Sci Rep. 2011;11:9548.","journal-title":"Sci Rep"},{"key":"4295_CR26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/RLI.0b013e318262292e","volume":"47","author":"JA Zach","year":"2012","unstructured":"Zach JA, et al. Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol. 2012;47:596\u2013602.","journal-title":"Invest Radiol"},{"key":"4295_CR27","doi-asserted-by":"publisher","first-page":"108046","DOI":"10.1016\/j.rmed.2025.108046","volume":"240","author":"A Takizawa","year":"2025","unstructured":"Takizawa A, et al. Exploring the pathophysiology of anemia in COPD: Insights from chest CT and longitudinal clinical data. Respir Med. 2025;240:108046.","journal-title":"Respir Med"},{"key":"4295_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"4295_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.resinv.2014.03.003","volume":"52","author":"M Kubota","year":"2014","unstructured":"Kubota M, et al. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52:242\u201350.","journal-title":"Respir Investig"},{"key":"4295_CR30","unstructured":"World Health Organization. Prevention and management of osteoporosis. World Health Org. Tech. Rep. 2003;921:1\u2013164 (2003)."},{"key":"4295_CR31","first-page":"1357","volume":"9","author":"DD Yoshimoto","year":"2014","unstructured":"Yoshimoto DD, Nakano Y, Onishi K, Hagan G, Jones P. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history. Int J Chron Obstruct Pulmon Dis. 2014;9:1357\u201363.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4295_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1183\/09031936.00125612","volume":"42","author":"PW Jones","year":"2013","unstructured":"Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: Implications for the GOLD 2011 classification. Eur Respir J. 2013;42:647\u201354.","journal-title":"Eur Respir J"},{"key":"4295_CR33","first-page":"141","volume":"150","author":"M Miravitlles","year":"2019","unstructured":"Miravitlles M, et al. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study. Respir. Med. 2019;150:141\u20138.","journal-title":"Med"},{"key":"4295_CR34","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.chest.2019.06.035","volume":"156","author":"A Balasubramanian","year":"2019","unstructured":"Balasubramanian A, et al. Diffusing capacity of carbon monoxide in assessment of COPD. Chest. 2019;156:1111\u20139.","journal-title":"Chest"},{"key":"4295_CR35","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/rccm.201105-0939PP","volume":"185","author":"C Laurin","year":"2012","unstructured":"Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012;185:918\u201323.","journal-title":"Am J Respir Crit Care Med"},{"key":"4295_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1183\/09031936.05.00078504","volume":"26","author":"G Gudmundsson","year":"2005","unstructured":"Gudmundsson G, et al. Risk factors for rehospitalisation in COPD: Role of health status, anxiety, and depression. Eur Respir J. 2005;26:414\u20139.","journal-title":"Eur Respir J"},{"key":"4295_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1378\/chest.08-0078","volume":"135","author":"JN de Voogd","year":"2009","unstructured":"de Voogd JN, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135:619\u201325.","journal-title":"Chest"},{"key":"4295_CR38","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1249\/01.MSS.0000142378.98039.58","volume":"36","author":"J Garcia-Aymerich","year":"2004","unstructured":"Garcia-Aymerich J, et al. Physical activity and its determinants in severe chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2004;36:1667\u201373.","journal-title":"Med Sci Sports Exerc"},{"key":"4295_CR39","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2147\/COPD.S77562","volume":"10","author":"AL Lee","year":"2015","unstructured":"Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: Links and risks. Int J Chron Obstruct Pulmon Dis. 2015;10:1935\u201349.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4295_CR40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/thx.2007.092858","volume":"63","author":"K Terada","year":"2008","unstructured":"Terada K, et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax. 2008;63:951\u20135.","journal-title":"Thorax"},{"key":"4295_CR41","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1007\/s10620-010-1542-5","volume":"56","author":"IE Rascon-Aguilar","year":"2011","unstructured":"Rascon-Aguilar IE, Pamer M, Wludyka P, Cury J, Vega KJ. Poorly treated or unrecognized GERD reduces quality of life in patients with COPD. Dig Dis Sci. 2011;56:1976\u201380.","journal-title":"Dig Dis Sci"},{"key":"4295_CR42","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/resp.12758","volume":"21","author":"L Baumeler","year":"2016","unstructured":"Baumeler L, et al. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Respirology. 2016;21:883\u201390.","journal-title":"Respirology"},{"key":"4295_CR43","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.2147\/COPD.S157761","volume":"13","author":"VY Su","year":"2018","unstructured":"Su VY, et al. Proton pump inhibitor use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD. Int J Chron Obstruct Pulmon Dis. 2018;13:2907\u201315.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4295_CR44","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2147\/COPD.S312560","volume":"16","author":"E Mekov","year":"2021","unstructured":"Mekov E, et al. Update on asthma\u2013COPD overlap (ACO): A narrative review. Int J Chron Obstruct Pulmon Dis. 2021;16:1783\u201399.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4295_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.rmed.2017.08.012","volume":"131","author":"H Irie","year":"2017","unstructured":"Irie H, et al. Characteristics of patients with increasing COPD assessment test scores within 3 years. Respir Med. 2017;131:101\u20138.","journal-title":"Respir Med"},{"key":"4295_CR46","first-page":"255","volume":"70","author":"T Mochimaru","year":"2021","unstructured":"Mochimaru T, et al. Blood eosinophil and neutrophil counts differentially identify frequent exacerbation in patients with COPD with physician-diagnosed asthma and COPD. Allergol. Int. 2021;70:255\u20137.","journal-title":"Int"},{"key":"4295_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/02770903.2011.555576","volume":"48","author":"P Kauppi","year":"2011","unstructured":"Kauppi P, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48:279\u201385.","journal-title":"J Asthma"},{"key":"4295_CR48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3109\/15412555.2012.671869","volume":"4","author":"JW Dodd","year":"2012","unstructured":"Dodd JW, et al. The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD. 2012;4:390\u20134.","journal-title":"COPD"},{"key":"4295_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/COPD.S74645","volume":"10","author":"J Sundh","year":"2015","unstructured":"Sundh J, et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173\u201383.","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04295-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:02:41Z","timestamp":1779933761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04295-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4295"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04295-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committees of Keio University and its affiliated hospitals, and all participants provided written informed consent for the use of their data. This study adhered to the principles of the Declaration of Helsinki, as adopted at the 59th World Medical Association General Assembly in Seoul, Korea, in October 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}